SEC Form 4 · accession 0001562180-19-000755
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Asha Das
Officer — Chief Medical Officer
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 11:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)F1 | $4.56 | Feb 1, 2019 | A | 125,000 | A | — | Feb 1, 2029 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F15yr 20% On Vest beginning on 01-Feb-2019